You have 9 free searches left this month | for more free features.

recurrent childhood medulloblastoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment

Recruiting
  • Medulloblastoma
  • +2 more
  • Specialized Tumor Board Treatment Plan
  • San Diego, California
  • +3 more
Dec 28, 2022

Recurrent Medulloblastoma, Recurrent Brain Tumor, Childhood, Malignant Glioma Trial in Durham (PEP-CMV)

Recruiting
  • Recurrent Medulloblastoma
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jan 8, 2022

Medulloblastoma, Childhood Trial in Worldwide (177Lu-DTPA-omburtamab)

Terminated
  • Medulloblastoma, Childhood
  • Rochester, Minnesota
  • +9 more
Aug 15, 2022

Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Medulloblastoma, Childhood, Recurrent
  • AloCELYVIR
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús
Sep 29, 2022

Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

Recruiting
  • Brain Tumor
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta (CHOA)
Jul 24, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Childhood Choroid Plexus Tumor, Childhood Ependymoblastoma, Childhood Grade III Meningioma Trial in United States (palbociclib

Terminated
  • Childhood Choroid Plexus Tumor
  • +18 more
  • palbociclib isethionate
  • +2 more
  • Los Angeles, California
  • +10 more
Feb 10, 2021

Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma Trial in Houston (Laboratory Biomarker

Completed
  • Recurrent Childhood Medulloblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Natural Killer Cell Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Aug 31, 2020

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

CNS Embryonal Tumor, Embryonal Tumor With Multilayered Rosettes, C19MC-Altered, Germ Cell Tumor Trial in Minneapolis, Portland

Active, not recruiting
  • Central Nervous System Embryonal Neoplasm
  • +9 more
  • Minneapolis, Minnesota
  • +1 more
Oct 25, 2021

Based on Molecular Typing of Medulloblastoma in Children

Not yet recruiting
  • Medulloblastoma, Childhood
  • Prospective observational study, no intervention
  • (no location specified)
Jun 4, 2022

Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)

Active, not recruiting
  • Brain Tumor
  • +12 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 20, 2022

Medulloblastoma, Childhood, Childhood Cancer Trial in Cairo (Dual Task Training Program Group, Control Group)

Completed
  • Medulloblastoma, Childhood
  • Childhood Cancer
  • Dual Task Training Program Group
  • Control Group
  • Cairo, Egypt
    Children's Cancer Hospital Egypt 57357
Nov 7, 2022

Medulloblastoma Trial in Houston (Treatment with MTX110)

Recruiting
  • Medulloblastoma
  • Treatment with MTX110
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 30, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Recurrent Medulloblastoma Trial in Beijing (Apatinib Combined With Temozolomide and Etoposide Capsules)

Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
Feb 10, 2022

Childhood Choroid Plexus Tumor, Childhood Medulloblastoma, Childhood Pineoblastoma Trial in Detroit (filgrastim)

Terminated
  • Childhood Choroid Plexus Tumor
  • +10 more
  • filgrastim
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Oct 2, 2020

Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)

Terminated
  • Neuroblastoma
  • Medulloblastoma
  • TPI 287
  • San Diego, California
  • +7 more
Apr 20, 2022

Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)

Active, not recruiting
  • Medulloblastoma
  • Neuroectodermal Tumor
  • TTRNA-xALT
  • TTRNA-DCs
  • Los Angeles, California
  • +2 more
Jan 7, 2022

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

    Active, not recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
    • Los Angeles, California
    • +18 more
    Aug 16, 2022

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023